Yoroidaka, T., Takamatsu, H., Urushihara, R., Itagaki, M., Yoshihara, S., Sato, K., Takezako, N., Ozaki, S., Suzuki, K., Kohno, K., Muta, T., Matsumoto, M., Terasaki, Y., Yamashita, T., Fuchida, S.- ichi, Sakamoto, J., Ishida, T., Suzuki, K., Murakami, H., Durie, B. G. and Shimizu, K. (2025) “Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study”, Haematologica. Pavia, Italy, 110(9), pp. 2160-2170. doi: 10.3324/haematol.2025.287411.